Characterization of the NMDA Receptor in Schizophrenia - David Grosshans

Abstract

Funding Agency

Agency: National Institute of Health (NIH)
Institute: National Institute of Mental Health (NIMH)
Type: Individual Predoctoral NRSA for M.D./Ph.D. Fellowships (ADAMHA) (F30)
Project #: 5F30MH012822-03
Application #: 6528626
Study Section: Special Emphasis Panel (ZRG1-BDCN-2 (02))
Program Officer: Curvey, Mary F

Project Start: 2002-08-01
Project End
Budget Start: 2002-08-01
Budget End: 2003-07-31
Support Year: 3
Fiscal Year: 2002
Total Cost: $30,338
Indirect Cost

Institution

Name: University of Colorado Denver
Department: Pharmacology
Type: Schools of Medicine
DUNS #: 065391526

City: Aurora
State: CO
Country: United States
Zip Code: 80045

Related projects


NIH 2003 F30 MH	Characterization of the NMDA Receptor in Schizophrenia Grosshans, David R. / University of Colorado Denver	$28,968
NIH 2002 F30 MH	Characterization of the NMDA Receptor in Schizophrenia Grosshans, David R. / University of Colorado Denver	$30,338
NIH 2001 F30 MH	Characterization of the NMDA Receptor in Schizophrenia Grosshans, David R. / University of Colorado Denver	$21,407
NIH 2000 F30 MH	Characterization of the NMDA Receptor in Schizophrenia Grosshans, David R. / University of Colorado Denver	$19,937

Comments

Be the first to comment on David Grosshans's grant